A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.
What is the purpose of this trial?
The primary objective of the study is to assess the diagnostic efficacy (specificity and sensitivity) of flurpiridaz F18 injection PET myocardial perfusion imaging (MPI) compared to single photon emission computed tomography (SPECT) MPI in the detection of significant coronary artery disease (CAD) as defined by invasive coronary angiography (ICA) or a documented history of Myocardial Infarction (MI).
- 18 Years - N/A
- Lantheus Medical Imaging
- June 2011
- Last Updated:
- August 14, 2014
- Study HIC#:
Clinicaltrials.gov ID: NCT01347710